The Top 10 DividendRank'ed Nasdaq 100 ComponentsBy The Online Investor Staff, updated Sat., Nov. 17, 2:07 AM
|This Slide: #1 of 10|
#10. Shire Plc (Jersey) (NASDAQ:SHPG) — 0.2% YIELD
Shire is a holding company. Through its subsidiaries, Co. operates as a biotechnology company focused on serving people with rare diseases and other conditions. Co.'s portfolio covers seven therapeutic areas: Immunology, Hematology, Neuroscience, Internal Medicine (IM), Genetic Diseases, Oncology, and Ophthalmics. Some of Co.'s marketed products include GAMMAGARD, HYQVIA and CINRYZE for Immunology, ADVATE/ADYNOVATE, VONVENDI and FEIBA for Hematology, VYVANSE and ADDERALL XR for Neuroscience, LIALDA/MEZAVANT and PENTASA for IM, ELAPRASE and REPLAGAL for Genetic Diseases, ONCASPAR and ONYVIDE for Oncology and XIIDRA for Ophthalmics.
Buy (3.27 out of 4)
(ranked higher than approx. 51% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite